Purple Biotech Ltd
PPBT
$2.53
-$0.1193-4.50%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | 4.13% | 4.13% | 1.99% | ||
| Total Depreciation and Amortization | -4.00% | -4.00% | -5.66% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -380.15% | -380.15% | -152.82% | ||
| Change in Net Operating Assets | -33.67% | -33.67% | 351.10% | ||
| Cash from Operations | -36.27% | -36.27% | 30.00% | ||
| Capital Expenditure | -100.00% | -100.00% | 200.00% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -92.64% | -92.64% | 405.03% | ||
| Cash from Investing | -92.64% | -92.64% | 408.08% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | ||
| Issuance of Common Stock | -99.41% | 638.05% | 39.51% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 6,793.75% | -1,018.75% | 16.88% | ||
| Cash from Financing | 642.31% | 642.31% | 55.86% | ||
| Foreign Exchange rate Adjustments | 335.00% | 335.00% | 13.04% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 70.69% | 70.69% | 55.18% | ||